FigitumumabAgricultural BiotechnologyUpdated on May 7, 2020 View more like this | Visit SHIRLEY, NY | Contact Bella Smith |

Recombinant monoclonal antibody to IGF1 Receptor. Figitumumab (previously CP-751871) is a monoclonal antibody targeting the insulin-like growth factor-1 receptor being investigated for the treatment of various types of cancer, for example adrenocortical carcinoma and non-small cell lung cancer (NSCLC).